Sanofi-Aventis
Seoul, Korea, Republic of
Pharmaceutical company in Seoul
Seoul, Seocho-gu, Banpo-daero, 235
About Sanofi-Aventis
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Sanofi
16
Clinical Trials at Sanofi-Aventis
During the past decade, Sanofi-Aventis conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
PREVAIL: PREvention of VTE After Acute Ischemic Stroke With LMWH Enoxaparin ( - VTE: Venous Thromboembolism - LMWH: Low Molecular Weight Heparin)
2003-08-01
Completed
Hexadecasaccharide (SR123781A) in Patients With Unstable Angina or Non-ST-Segment Elevation Myocardial Infarction
2004-12-01
2007-05-01
Completed
1,257
Opposing Step-by-step Insulin Reinforcement to Intensified Strategy
2004-12-01
Completed
811
MASCOT : Multicenter Asia Study in Adjuvant Treatment of Colon Cancer With OxaliplaTin/5FU-LV
2004-08-01
Completed
Study of Weight-Reducing Effect and Safety of Rimonabant In Obesity in ASIA (RIO-ASIA)
2006-04-01
2007-04-01
Completed
643
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Sanofi-Aventis"
#1 collaborator was "Bristol-Myers Squibb" with 1 trials as a collaborator, "Cancer International Research Group (CIRG)" with 1 trials as a collaborator and "Hoffmann-La Roche" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at Sanofi-Aventis
According to Clinical.Site data, the most researched conditions in "Sanofi-Aventis" are
"Diabetes Mellitus, Type 2" (2 trials), "Acute Ischemic Stroke" (1 trials), "BPH/LUTS/Sexual Functions" (1 trials), "Breast Cancer" (1 trials) and "Carcinoma, Squamous Cell" (1 trials). Many other conditions were trialed in "Sanofi-Aventis" in a lesser frequency.
Clinical Trials Intervention Types at Sanofi-Aventis
Most popular intervention types in "Sanofi-Aventis" are "Drug" (16 trials). Other intervention types were less common.
The name of intervention was led by "Docetaxel" (2 trials), "Insulin glargine" (2 trials), "Metformin" (2 trials), "Oxaliplatin" (2 trials) and "Alfuzosin" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Sanofi-Aventis
The vast majority of trials in "Sanofi-Aventis" are
13 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.
Clinical Trials Status at Sanofi-Aventis
Currently, there are NaN active trials in "Sanofi-Aventis".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 16 completed trials in Sanofi-Aventis,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Sanofi-Aventis, 0 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 8 trials, and there were
also 0 trials that are defined as “Not Applicable".